Literature DB >> 10094970

Two control elements in the hepatitis B virus S-promoter are important for full promoter activity mediated by CCAAT-binding factor.

C T Bock1, S Kubicka, M P Manns, C Trautwein.   

Abstract

Natural occurring mutations in the preS-region are frequently found during chronic hepatitis B virus (HBV) infection. Here we used the mutated preS-region from a patient to study the transcriptional regulation of the S-promoter. The mutations were a CCAAT-box (MUT1) point mutation, a 6-base pair (bp) deletion (MUT2) 3' of the CCAAT-box, and a 153 bp deletion (MUT3) in the preS2 genome. Transfection experiments revealed for MUT1 and 2 30% to 40% and MUT3 75% of the wildtype (wt) S-promoter activity. In electro-mobility shift assays experiments, binding of a nuclear protein was impaired with MUT1. Ultraviolet cross-linking, South-Western, and gel shift experiments revealed a 30- to 40-kd protein interacting with the wt CCAAT-motif. Computer-assisted analysis and supershift experiments showed that CCAAT-binding factor (CBF) is the CCAAT-box binding protein. Cotransfection experiments with expression vectors for dominant-negative CBF or wt CBF showed that the wt S-promoter but not MUT1 could be regulated through CBF. Additionally, the CBF constructs did not modulate the basal activity of MUT2 but changes the activity of MUT3 like wt HBV. Artificial mutations were introduced in the MUT2 reporter constructs. Transfection experiments revealed that wt promoter activity could not be reconstituted. Therefore these experiments indicated the sterical position of CBF being essential for full S-promoter activity. Our study shows that the CCAAT-box and a second region is essential to mediate full S-promoter activity dependent on CBF. As these mutations also lead to retention of S-protein in the endoplasmic reticulum our results indicate that mutational changes in the preS-region might be linked to the progression of HBV-related liver disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10094970     DOI: 10.1002/hep.510290426

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  24 in total

Review 1.  Genetic variation of occult hepatitis B virus infection.

Authors:  Hui-Lan Zhu; Xu Li; Jun Li; Zhen-Hua Zhang
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

2.  HoxA10 Facilitates SHP-1-Catalyzed Dephosphorylation of p38 MAPK/STAT3 To Repress Hepatitis B Virus Replication by a Feedback Regulatory Mechanism.

Authors:  Qingyu Yang; Qi Zhang; Xuewu Zhang; Lei You; Wenbiao Wang; Weiyong Liu; Yang Han; Chunqiang Ma; Wei Xu; Junbo Chen; Hua Yang; Pin Wan; Yao Zhou; Yingle Liu; Kailang Wu; Ziwen Yang; Jianguo Wu
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

Review 3.  Molecular biology of hepatitis B virus: effect of nucleotide substitutions on the clinical features of chronic hepatitis B.

Authors:  Osamu Yokosuka; Makoto Arai
Journal:  Med Mol Morphol       Date:  2006-09       Impact factor: 2.309

4.  TIP60 Complex Inhibits Hepatitis B Virus Transcription.

Authors:  Hironori Nishitsuji; Saneyuki Ujino; Keisuke Harada; Kunitada Shimotohno
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

5.  Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B.

Authors:  Pok Yeung; Danny Ka-Ho Wong; Ching-Lung Lai; James Fung; Wai-Kay Seto; Man-Fung Yuen
Journal:  J Infect Dis       Date:  2011-01-12       Impact factor: 5.226

6.  Characterization of contrasting features between hepatitis B virus genotype A and genotype D in small envelope protein expression and surface antigen secretion.

Authors:  Fei Zhang; Xiaoli Tang; Tamako Garcia; Anna S Lok; Yongxiang Wang; Haodi Jia; Yanli Qin; Chaoyang Chen; Yumei Wen; Jisu Li; Shuping Tong
Journal:  Virology       Date:  2017-01-23       Impact factor: 3.616

7.  Molecular phenotypes of human parvovirus B19 in patients with myocarditis.

Authors:  C-Thomas Bock; Anja Düchting; Friederike Utta; Eva Brunner; Bui Tien Sy; Karin Klingel; Florian Lang; Meinrad Gawaz; Stephan B Felix; Reinhard Kandolf
Journal:  World J Cardiol       Date:  2014-04-26

8.  Effects of two novel nucleoside analogues on different hepatitis B virus promoters.

Authors:  Xing-Xing He; Ju-Sheng Lin; Ying Chang; Ying-Hui Zhang; Yan Li; Xiao-Yan Wang; Dong Xu; Xiao-Ming Cheng
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

9.  Enhancer I predominance in hepatitis B virus gene expression.

Authors:  Gilad Doitsh; Yosef Shaul
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

10.  MicroRNAs in Liver Health and Disease.

Authors:  Shu-Hao Hsu; Kalpana Ghoshal
Journal:  Curr Pathobiol Rep       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.